clofibrate has been researched along with warfarin in 57 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 44 (77.19) | 18.7374 |
1990's | 3 (5.26) | 18.2507 |
2000's | 1 (1.75) | 29.6817 |
2010's | 9 (15.79) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alvarez-Pedraglio, A; Colmenarejo, G; Lavandera, JL | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Fent, K; Popovic, M; Smital, T; Zaja, R | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
Graham, GG; Pond, SM; Sudlow, G; Wade, DN | 1 |
Etherington, MD; O'Brien, JR | 1 |
Bjornsson, TD; Blaschke, TF; Meffin, PJ; Swezey, S | 1 |
Bjornsson, TD; Blaschke, TF; Meffin, PJ; Swezey, SE | 1 |
Kapoor, A; Veronich, K; White, G | 1 |
Karlsson, H; Lagercrantz, C; Larsson, T | 1 |
Hladovec, J | 1 |
Meisner, H; Taylor, S | 1 |
Bjornsson, TD; Blaschke, TF; Meffin, PJ | 1 |
Phillips, WA; Ratchford, JM; Schultz, JR | 1 |
Griffin, JP; Parkins, A; Williams, JR | 1 |
Gent, M; Genton, E; Harker, LA; Hirsh, J | 1 |
Gibson, GG; MacNicoll, AD; Sutcliffe, FA | 1 |
Feller, DR; Kim, SK; Newman, HA; Romstedt, K; Witiak, DT | 1 |
Bachmann, KA; Jahn, D; Schwartz, J; Yang, C | 1 |
O'Reilly, RA | 3 |
Balfour, C; Dunbar, D; Halpert, J; Kaminsky, LS; Miller, NE; Morgan, ET | 1 |
Hucker, HB; Stauffer, SC; White, SE | 1 |
Eastham, RD | 2 |
McQueen, EG | 1 |
O'Reilly, RA; Robinson, AJ; Sahud, MA | 1 |
Sellers, E; Weser, JK | 1 |
Corrigan, JJ; Marcus, FI | 1 |
Rosner, F; Solomon, RB | 1 |
Eipe, J | 1 |
Thonnard-Neumann, E | 1 |
Blatrix, C; Thebault, J; Tillement, JP | 1 |
Nies, AS | 1 |
Aleksandrov, AA; Kokurina, EV; Metelitsa, VI; Ostrovskaia-Tsarfis, TP; Sapozhnikov, II | 1 |
Mattei, C; Tillement, JP; Zini, R | 1 |
Aggeler, PM; O'Reilly, RA | 1 |
Cagăn, S; Cagãnovă, A | 1 |
Petrie, JC; Starr, KJ | 1 |
Abrams, WB; Reich, S; Solomon, HM; Spirt, N | 1 |
Barre, J; D'Athis, P; Tillement, JP; Zini, R | 1 |
O'Brien, JR | 1 |
Basi, N; Bruseghini, L; Sanfeliu, C; Vilageliu, J; Zapatero, J | 1 |
Blaauboer, BJ; Luijckx, NB; Mennes, WC; Noordhoek, J; Wortelboer, HM | 1 |
Miller, DB; Spence, JD | 1 |
BERSOHN, I; HAYES, D; OLIVER, MF; PANTRIDGE, JF; ROBERTS, SD; SUZMAN, MM | 1 |
COOK, IJ; DETOSZEGHI, A; SYMONS, C | 1 |
13 review(s) available for clofibrate and warfarin
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Hypervitaminosis E and coagulation.
Topics: Animals; Blood Coagulation Disorders; Blood Coagulation Factors; Clofibrate; Ecchymosis; Humans; Male; Middle Aged; Prothrombin Time; Vitamin E; Vitamin K; Warfarin | 1975 |
Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (first of three parts).
Topics: Animals; Antidepressive Agents, Tricyclic; Aspirin; Blindness; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Clofibrate; Dipyridamole; Drug Therapy, Combination; Fibrinolytic Agents; Heart Valve Prosthesis; Humans; Ischemic Attack, Transient; Male; Prospective Studies; Pyrimidines; Retrospective Studies; Sulfinpyrazone; Thromboembolism; Warfarin | 1975 |
Warfarin metabolism and drug-drug interactions.
Topics: Anti-Bacterial Agents; Aspirin; Barbiturates; Cholestyramine Resin; Clofibrate; Diuretics; Drug Interactions; Ethanol; Humans; Rifampin; Vitamin K; Warfarin | 1987 |
The pharmacodynamics of the oral anticoagulant drugs.
Topics: Administration, Oral; Animals; Anticoagulants; Blood Coagulation; Blood Coagulation Factors; Blood Proteins; Clofibrate; Coumarins; Dicumarol; Disulfiram; Ethyl Biscoumacetate; Female; Heparin; Intestinal Absorption; Liver; Phenylbutazone; Protein Binding; Prothrombin; Prothrombin Time; Rabbits; Rats; Salicylates; Sulfonamides; Vitamin K; Vitamin K Deficiency; Warfarin | 1974 |
Hazards of anticoagulant treatment: other drugs, other diseases.
Topics: Administration, Oral; Animals; Anticoagulants; Barbiturates; Biological Transport; Blood Coagulation Factors; Clofibrate; Cycloheptanes; Depression, Chemical; Dicumarol; Disulfiram; Drug Interactions; Drug Synergism; Feces; Female; Half-Life; Humans; Hypoprothrombinemias; Infant, Newborn; Phenylbutazone; Pregnancy; Prothrombin Time; Rats; Receptors, Drug; Serum Albumin; Vitamin K Deficiency; Warfarin | 1973 |
Drug interactions with coumarin anticoagulants. 2.
Topics: Allopurinol; Anabolic Agents; Animals; Anti-Bacterial Agents; Anticoagulants; Barbiturates; Chloral Hydrate; Chloramphenicol; Cholestyramine Resin; Clofibrate; Contraceptives, Oral; Coumarins; Dextrothyroxine; Diuretics; Drug Antagonism; Drug Synergism; Ethacrynic Acid; Ethanol; Glucagon; Glucocorticoids; Glutethimide; Humans; Oxyphenbutazone; Phenylbutazone; Quinidine; Quinine; Quinolines; Salicylates; Sulfinpyrazone; Sulfonamides; Thyroid Hormones; Tolbutamide | 1971 |
Drugs affecting therapy with anticoagulants.
Topics: Anticoagulants; Chloramphenicol; Clofibrate; Contraceptives, Oral; Coumarins; Diuretics; Drug Interactions; Drug Synergism; Drug-Related Side Effects and Adverse Reactions; Estrogens; Ethanol; Heparin; Humans; Hypnotics and Sedatives; Phenylbutazone; Phenytoin; Salicylates; Thyroxine; Tolbutamide; Vitamin K | 1972 |
Heparin in migraine headache.
Topics: Adult; Aged; Basophils; Blood Cell Count; Clofibrate; Female; Hematuria; Heparin; Humans; Immunoglobulins; Injections, Intravenous; Lipids; Male; Middle Aged; Migraine Disorders; Warfarin | 1973 |
Drug interactions.
Topics: Anabolic Agents; Antidepressive Agents; Biological Transport, Active; Cholestyramine Resin; Clofibrate; Drug Interactions; Humans; Hydrogen-Ion Concentration; Intestinal Absorption; Kaolin; Kidney; Pharmaceutical Preparations; Phenylbutazone; Probenecid; Protein Binding; Thyroxine; Warfarin | 1974 |
Determinants of the response to oral anticoagulant drugs in man.
Topics: Administration, Oral; Adrenal Cortex Hormones; Animals; Anti-Bacterial Agents; Anticoagulants; Blood Coagulation; Blood Coagulation Disorders; Blood Coagulation Factors; Clofibrate; Coumarins; Diuresis; Dogs; Heparin; Humans; Hypnotics and Sedatives; Liver Diseases; Metabolic Diseases; Phenylbutazone; Rats; Salicylates; Sulfonamides; Thrombosis; Uremia; Vitamin K | 1970 |
Hypothesis: polypharmacy. The treatment of thrombotic risk.
Topics: Aspirin; Blood Coagulation Tests; Clofibrate; Hemorrhage; Heparin; Humans; Thrombosis; Warfarin | 1980 |
Clinical pharmacokinetics of fibric acid derivatives (fibrates).
Topics: Anticholesteremic Agents; Clofibrate; Cyclosporine; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Drug Interactions; Fenofibrate; Gemfibrozil; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Liver; Mixed Function Oxygenases; Warfarin | 1998 |
3 trial(s) available for clofibrate and warfarin
Article | Year |
---|---|
Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (first of three parts).
Topics: Animals; Antidepressive Agents, Tricyclic; Aspirin; Blindness; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Clofibrate; Dipyridamole; Drug Therapy, Combination; Fibrinolytic Agents; Heart Valve Prosthesis; Humans; Ischemic Attack, Transient; Male; Prospective Studies; Pyrimidines; Retrospective Studies; Sulfinpyrazone; Thromboembolism; Warfarin | 1975 |
Studies on the interaction of warfarin and clofibrate in man.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Adult; Blood Coagulation; Blood Platelets; Cell Count; Clofibrate; Drug Interactions; Factor IX; Factor VII; Factor X; Hemorrhagic Disorders; Humans; Hypoprothrombinemias; Male; Phosphoric Monoester Hydrolases; Platelet Adhesiveness; Prothrombin Time; Time Factors; Warfarin | 1972 |
Ischaemic heart disease: a secondary prevention trial using clofibrate. Report by a research committee of the Scottish Society of Physicians.
Topics: Adult; Aged; Angina Pectoris; Cholesterol; Clinical Trials as Topic; Clofibrate; Coronary Disease; Electrocardiography; Female; Humans; Male; Middle Aged; Myocardial Infarction; Placebos; Prognosis; Warfarin | 1971 |
42 other study(ies) available for clofibrate and warfarin
Article | Year |
---|---|
Cheminformatic models to predict binding affinities to human serum albumin.
Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Chromatography, Affinity; Cyclooxygenase Inhibitors; Databases, Factual; Humans; Hydrophobic and Hydrophilic Interactions; Penicillins; Pharmaceutical Preparations; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Serum Albumin; Steroids | 2001 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics | 2011 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Molecular characterization of zebrafish Oatp1d1 (Slco1d1), a novel organic anion-transporting polypeptide.
Topics: Animals; Evolution, Molecular; Glycosylation; Gonadal Steroid Hormones; HEK293 Cells; Humans; Ion Transport; Organic Anion Transporters; Protein Multimerization; Zebrafish; Zebrafish Proteins | 2013 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
The effects of allopurinol and clofibrate on the elimination of coumarin anticoagulants in man.
Topics: Adult; Allopurinol; Biological Availability; Blood Proteins; Butyrates; Clofibrate; Dicumarol; Half-Life; Humans; Male; Protein Binding; Warfarin | 1975 |
Effect of heparin and warfarin on antithrombin III.
Topics: Antithrombins; Clofibrate; Drug Antagonism; Heparin; Humans; Thrombophlebitis; Warfarin | 1977 |
Clofibrate displaces warfarin from plasma proteins in man: an example of a pure displacement interaction.
Topics: Administration, Oral; Adult; Binding, Competitive; Blood Coagulation; Blood Proteins; Clofibrate; Drug Interactions; Humans; Injections, Intravenous; Kinetics; Male; Protein Binding; Warfarin | 1979 |
Effects of clofibrate and warfarin alone and in combination on the disposition of vitamin K1.
Topics: Adult; Clofibrate; Drug Interactions; Epoxy Compounds; Humans; Kinetics; Male; Vitamin K 1; Warfarin | 1979 |
Effects of phenylbutazone, tolbutamide, and clofibric acid on binding of racemic warfarin and its enantiomers to human serum albumin.
Topics: Binding, Competitive; Clofibrate; Clofibric Acid; Humans; Kinetics; Phenylbutazone; Protein Binding; Serum Albumin; Stereoisomerism; Tolbutamide; Warfarin | 1979 |
Binding of some fatty acids and drugs to immobilized bovine serum albumin studied by column affinity chromatography.
Topics: Animals; Binding Sites; Binding, Competitive; Caprylates; Cattle; Chromatography, Affinity; Clofibrate; Estradiol; Fatty Acids; Kinetics; Mathematics; Pharmaceutical Preparations; Protein Binding; Salicylates; Serum Albumin, Bovine; Warfarin | 1979 |
Vasotropic drugs--a survey based on a unifying concept of their mechanism of action.
Topics: Animals; Aspirin; Blood Vessels; Calcium Dobesilate; Clofibrate; Coumarins; Dose-Response Relationship, Drug; Drug Combinations; Female; Flavonoids; Glycosides; Pyrithioxin; Rats; Rutin; Vasomotor System | 1977 |
Antilipolytic effects of chlorophenoxyisobutyrate and warfarin in adipocytes.
Topics: Adipose Tissue; Animals; Clofibrate; Fatty Acids, Nonesterified; Kinetics; Lipid Mobilization; Male; Rats; Serum Albumin, Bovine; Warfarin | 1978 |
Interaction of clofibrate with warfarin. I. Effect of clofibrate on the disposition of the optical enantiomorphs of warfarin.
Topics: Adult; Clofibrate; Drug Interactions; Humans; Male; Stereoisomerism; Warfarin | 1977 |
Effects of colestipol hydrochloride on drug absorption in the rat II.
Topics: Animals; Cellulose; Chlorpromazine; Cholestyramine Resin; Clofibrate; Colestipol; Digitoxin; Digoxin; Hydrochlorothiazide; Intestinal Absorption; Male; Nicotinic Acids; Pharmaceutical Preparations; Phenobarbital; Polyamines; Rats; Tetracycline; Warfarin | 1976 |
Effect of concomitantly administered drugs on the control of long term anticoagulant therapy.
Topics: Allopurinol; Anabolic Agents; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Antidepressive Agents, Tricyclic; Barbiturates; Clofibrate; Digoxin; Diuretics; Drug Administration Schedule; Drug Interactions; Ethanol; Female; Humans; Hypoglycemic Agents; Male; Phenothiazines; Warfarin | 1976 |
Hepatic microsomal warfarin metabolism in warfarin-resistant and susceptible mouse strains: influence of pretreatment with cytochrome P-450 inducers.
Topics: Animals; Benzoflavones; beta-Naphthoflavone; Clofibrate; Cytochrome P-450 Enzyme System; Drug Resistance; Enzyme Induction; Female; Male; Mice; Microsomes, Liver; Phenobarbital; Sex Factors; Species Specificity; Stereoisomerism; Warfarin | 1990 |
Comparative antiaggregatory activity in human platelets of a benzopyranone aci-reductone, clofibric acid, and a 2,3-dihydrobenzofuran analogue.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Arachidonic Acid; Arachidonic Acids; Benzofurans; Blood Platelets; Clofibrate; Clofibric Acid; Coumarins; Humans; In Vitro Techniques; Platelet Aggregation; Prostaglandin Endoperoxides, Synthetic; Serotonin; Structure-Activity Relationship | 1986 |
The use of single sample clearance estimates to probe hepatic drug metabolism in rats. II.
Topics: Animals; Antipyrine; Benzoflavones; beta-Naphthoflavone; Clofibrate; Drug Interactions; Liver; Male; Metabolic Clearance Rate; Pharmaceutical Preparations; Phenobarbital; Rats; Rats, Inbred Strains; Safrole; Theophylline; Valproic Acid; Warfarin | 1988 |
Isozyme selectivity of the inhibition of rat liver cytochromes P-450 by chloramphenicol in vivo.
Topics: Animals; Benzoflavones; beta-Naphthoflavone; Chloramphenicol; Clofibrate; Cytochrome P-450 Enzyme Inhibitors; Isoenzymes; Lauric Acids; Liver; Male; Mixed Function Oxygenases; Phenobarbital; Pregnenolone Carbonitrile; Rats; Rats, Inbred Strains; Safrole; Steroid 16-alpha-Hydroxylase; Substrate Specificity; Testosterone; Warfarin | 1985 |
Effect of halofenate on binding of various drugs to human plasma proteins and on the plasma half-life of antipyrine in monkeys.
Topics: Acetamides; Animals; Anticholesteremic Agents; Antipyrine; Aspirin; Blood Proteins; Carbon Isotopes; Chlorothiazide; Clofibrate; Dicumarol; Digitoxin; Drug Interactions; Fluorine; Glycolates; Half-Life; Haplorhini; Humans; Hypolipidemic Agents; Indomethacin; Macaca; Phenothiazines; Phenylbutazone; Salicylates; Warfarin | 1972 |
Warfarin dosage influenced by clofibrate plus age.
Topics: Adult; Age Factors; Clofibrate; Drug Interactions; Humans; Middle Aged; Warfarin | 1973 |
Drug displacement from protein-binding and redistributional interactions.
Topics: Animals; Blood Proteins; Carboxylic Acids; Clofibrate; DDT; Dieldrin; Guanidines; Hexachlorocyclohexane; Humans; Kinetics; Oxyphenbutazone; Pharmaceutical Preparations; Phenylbutazone; Phenytoin; Protein Binding; Rats; Sheep; Ultrafiltration; Warfarin | 1974 |
Coagulopathy associated with vitamin E ingestion.
Topics: Blood Coagulation Disorders; Blood Coagulation Factors; Blood Coagulation Tests; Clofibrate; Hemorrhage; Humans; Male; Methods; Middle Aged; Prothrombin Time; Pulmonary Embolism; Sodium; Vitamin E; Vitamin K; Vitamin K Deficiency; Warfarin | 1974 |
Massive hemorrhage and death during treatment with clofibrate and warfarin.
Topics: Aged; Clofibrate; Hematemesis; Hematuria; Hemorrhage; Humans; Male; Prothrombin Time; Warfarin | 1973 |
[Drug interactions with vitamin K antagonists].
Topics: Analgesics; Anti-Bacterial Agents; Anti-Inflammatory Agents; Anticoagulants; Antineoplastic Agents; Barbiturates; Benzofurans; Clofibrate; Coumarins; Diuretics; Drug Antagonism; Drug Interactions; Drug Synergism; Humans; Hypoglycemic Agents; Monoamine Oxidase Inhibitors; Salicylates; Steroids; Sulfonamides; Thyroxine; Vitamin K; Warfarin | 1973 |
Warfarin dosage, clofibrate, and age of patient.
Topics: Adult; Age Factors; Clofibrate; Drug Synergism; Humans; Middle Aged; Myocardial Infarction; Warfarin | 1973 |
[Value of epidemiological studies in validating primary and secondary prevention of ischemic heart disease].
Topics: Clofibrate; Coronary Disease; Coumarins; Exercise Therapy; Humans; Male; Middle Aged; Moscow; Prospective Studies; Vasodilator Agents | 1973 |
Effect of sodium chlorophenoxyisobutyrate on the binding of vitamin K antagonists to human albumin in vitro.
Topics: Acenocoumarol; Anticoagulants; Binding Sites; Clofibrate; Ethyl Biscoumacetate; Humans; Phenindione; Protein Binding; Receptors, Drug; Serum Albumin; Vitamin K; Warfarin | 1974 |
[Effects of long-term administration of Clofibrate Spofa on serum lipid level].
Topics: Adult; Aged; Cardiovascular Diseases; Clofibrate; Coumarins; Drug Interactions; Female; Humans; Lipids; Male; Middle Aged; Time Factors | 1972 |
Drug interactions in patients on long-term oral anticoagulant and antihypertensive adrenergic neuron-blocking drugs.
Topics: Adult; Aged; Amidines; Anticoagulants; Antidepressive Agents; Antihypertensive Agents; Barbiturates; Clofibrate; Drug Interactions; Female; Guanethidine; Guanidines; Humans; Male; Middle Aged; Phenindione; Quinolines; Salicylates; Self Medication; Sympatholytics; Sympathomimetics; Warfarin | 1972 |
Interactions between digitoxin and other drugs in vitro and in vivo.
Topics: Binding Sites; Cell Membrane Permeability; Chemical Phenomena; Chemistry; Clofibrate; Digitoxin; Digoxin; Drug Antagonism; Enzyme Induction; Erythrocytes; Humans; Microsomes, Liver; Phenobarbital; Phenylbutazone; Phenytoin; Protein Binding; Radioisotopes; Rubidium; Serum Albumin; Sulfadimethoxine; Tolbutamide; Tritium; Warfarin | 1971 |
Angina pectoris--II.
Topics: Adult; Aged; Angina Pectoris; Arrhythmias, Cardiac; Cholesterol; Cholestyramine Resin; Clofibrate; Diet; Female; Heart Failure; Humans; Hyperlipidemias; Hyperthyroidism; Male; Middle Aged; Myocardium; Oxygen Consumption; Pacemaker, Artificial; Propranolol; Warfarin | 1971 |
Binding of clometacin to human serum albumin. Interactions with clofibrate, indomethacin, salicylic acid and warfarin.
Topics: Analgesics; Clofibrate; Humans; Indoleacetic Acids; Indomethacin; Kinetics; Protein Binding; Salicylates; Salicylic Acid; Serum Albumin; Structure-Activity Relationship; Warfarin | 1983 |
Toxicological studies of plafibride. Part 4: Interaction of plafibride with other drugs.
Topics: Animals; Blepharoptosis; Blood Pressure; Body Temperature; Clofibrate; Clofibric Acid; Dogs; Drug Interactions; Mice; Rats; Rats, Inbred Strains; Reserpine; Warfarin | 1981 |
Differences in the effects of model inducers of cytochrome P450 on the biotransformation of scoparone in rat and hamster liver.
Topics: Animals; Antihypertensive Agents; Benzoflavones; beta-Naphthoflavone; Biotransformation; Clofibrate; Coumarins; Cricetinae; Cytochrome P-450 Enzyme System; Dexamethasone; Enzyme Induction; Guinea Pigs; Isoniazid; Liver; Male; Mesocricetus; Microsomes, Liver; Phenobarbital; Rats; Rats, Wistar; Species Specificity | 1993 |
Effect of atromid and ethyl chlorophenoxyisobutyrate on anticoagulant requirements.
Topics: Androsterone; Anticoagulants; Butyrates; Clofibrate; Coronary Disease; Hypercholesterolemia; Hyperlipidemias; Phenindione; Warfarin | 1963 |
EFFECT OF ETHYL CHLOROPHENOXYISOBUTYRATE WITH OR WITHOUT ANDROSTERONE ON PLATELET STICKINESS.
Topics: Androsterone; Biomedical Research; Blood Platelets; Butyrates; Cholesterol; Clofibrate; Drug Therapy; Humans; Myocardial Infarction; Pharmacology; Phenindione; Placebos; Warfarin | 1964 |